LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,815,739 | -3.9% | 614,392 | +15.6% | 0.01% | 0.0% |
| Q2 2023 | $38,316,126 | +10.9% | 531,422 | +13.1% | 0.01% | 0.0% |
| Q1 2023 | $34,565,541 | +112896.2% | 469,916 | +2.6% | 0.01% | +33.3% |
| Q4 2022 | $30,590 | -99.9% | 457,923 | +2.0% | 0.01% | -40.0% |
| Q3 2022 | $38,673,000 | -2.1% | 449,118 | +1.4% | 0.02% | +7.1% |
| Q2 2022 | $39,497,000 | -7.1% | 442,704 | +17.1% | 0.01% | +7.7% |
| Q1 2022 | $42,537,000 | -26.1% | 378,118 | +1.5% | 0.01% | -23.5% |
| Q4 2021 | $57,563,000 | +10.8% | 372,668 | -0.0% | 0.02% | 0.0% |
| Q3 2021 | $51,936,000 | -3.3% | 372,774 | -8.9% | 0.02% | 0.0% |
| Q2 2021 | $53,709,000 | -2.7% | 409,377 | +13.0% | 0.02% | -5.6% |
| Q1 2021 | $55,224,000 | +51.8% | 362,257 | -1.0% | 0.02% | +38.5% |
| Q4 2020 | $36,380,000 | +0.5% | 365,791 | -3.7% | 0.01% | -13.3% |
| Q3 2020 | $36,206,000 | -15.3% | 379,839 | -0.7% | 0.02% | -21.1% |
| Q2 2020 | $42,771,000 | +27.3% | 382,388 | -17.3% | 0.02% | +5.6% |
| Q1 2020 | $33,603,000 | -31.4% | 462,112 | -1.5% | 0.02% | 0.0% |
| Q4 2019 | $48,950,000 | +25.1% | 469,367 | +19.4% | 0.02% | +20.0% |
| Q3 2019 | $39,133,000 | +47.0% | 393,143 | +68.6% | 0.02% | +50.0% |
| Q2 2019 | $26,621,000 | -0.2% | 233,213 | +10.0% | 0.01% | -9.1% |
| Q1 2019 | $26,662,000 | -5.2% | 212,103 | +2.3% | 0.01% | -15.4% |
| Q4 2018 | $28,132,000 | -41.5% | 207,306 | +18.3% | 0.01% | -27.8% |
| Q3 2018 | $48,093,000 | +16.6% | 175,210 | -12.0% | 0.02% | +12.5% |
| Q2 2018 | $41,245,000 | +12.3% | 199,085 | -10.4% | 0.02% | +6.7% |
| Q1 2018 | $36,713,000 | +18.7% | 222,286 | -1.6% | 0.02% | +15.4% |
| Q4 2017 | $30,942,000 | -4.2% | 225,967 | -4.7% | 0.01% | -7.1% |
| Q3 2017 | $32,285,000 | +0.9% | 237,130 | -10.0% | 0.01% | -6.7% |
| Q2 2017 | $32,001,000 | +12.8% | 263,596 | -1.7% | 0.02% | +7.1% |
| Q1 2017 | $28,380,000 | +4.1% | 268,144 | -0.1% | 0.01% | 0.0% |
| Q4 2016 | $27,265,000 | -0.6% | 268,333 | -0.2% | 0.01% | -6.7% |
| Q3 2016 | $27,442,000 | -20.0% | 268,880 | -6.5% | 0.02% | -25.0% |
| Q2 2016 | $34,302,000 | -12.6% | 287,592 | -21.5% | 0.02% | -13.0% |
| Q1 2016 | $39,244,000 | -34.3% | 366,468 | -33.5% | 0.02% | -37.8% |
| Q4 2015 | $59,758,000 | +24.6% | 551,168 | -1.5% | 0.04% | +19.4% |
| Q3 2015 | $47,942,000 | -13.8% | 559,758 | +1.5% | 0.03% | -8.8% |
| Q2 2015 | $55,621,000 | +38.9% | 551,257 | +6.2% | 0.03% | +36.0% |
| Q1 2015 | $40,031,000 | +73.0% | 519,145 | +19.4% | 0.02% | +66.7% |
| Q4 2014 | $23,138,000 | +24.0% | 434,855 | +9.5% | 0.02% | +15.4% |
| Q3 2014 | $18,660,000 | -19.3% | 397,105 | +6.9% | 0.01% | -18.8% |
| Q2 2014 | $23,137,000 | +55.7% | 371,438 | +68.1% | 0.02% | +45.5% |
| Q1 2014 | $14,863,000 | +123.0% | 220,968 | +74.4% | 0.01% | +120.0% |
| Q4 2013 | $6,664,000 | +17910.8% | 126,687 | +14786.8% | 0.01% | – |
| Q3 2013 | $37,000 | +15.6% | 851 | 0.0% | 0.00% | – |
| Q2 2013 | $32,000 | – | 851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |